Latest filing published 07 Jan 2025 for NewAmsterdam Pharma Co N.V..
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +69.8%Entry US$17.29 · Close at T+365 US$29.36
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Juliette Berangere Audet: trading record in brief
Juliette Berangere Audet appears in our data through filings on NewAmsterdam Pharma Co N.V. shares, published by SEC (Form 4). Over a trading history stretching from 26 September 2024 to 7 January 2025, the count stands at 2 filings.
The open-market record is one-sided, with 1 purchase worth €16k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 1 share grant.
On 7 January 2025 came the latest disclosure, a share grant in NewAmsterdam Pharma Co N.V. The most recent open-market purchase was published on 30 September 2024, 770 days ago. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Juliette Berangere Audet
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 14,000 sharesOrdinary SharesSEC:0000950170-25-002996:0
- 1,104 shares@ US$15.70100.0% of flowOrdinary SharesSEC:0000950170-24-110440:0Canonical exit: 25 Dec 2024 (T+90)
2 of 2 declarations
